Skip to content
Back to announcement

20260604_KAEF_Ringkasan Risalah//Risalah RUPS_32097247_lamp3.pdf

RUPS minutes Needs review KAEF

Source file signed link, expires in 15 minutes

This browser can't display the PDF inline. Open it in a new tab.

Extracted text 13

Page 1
                                 ANNOUNCEMENT
            SUMMARY OF MINUTES OF GENERAL MEETING OF SHAREHOLDERS
                               OF FISCAL YEAR 2025
                          PT KIMIA FARMA (PERSERO) Tbk

The Board of Directors of PT Kimia Farma (Persero) Tbk (hereinafter referred to as the
“Company”), having its domicile in Central Jakarta, hereby announces that the Board of Directors
has convened the Company’s General Meeting of Shareholders of the Company for the Fiscal
Year 2025 (hereinafter referred to as the “Meeting”) on:
 Day/Date             : Wednesday, June 3, 2026
 Time                 : 14.53 WIB until 17.56 WIB
 Venue                : Access the KSEI Electronic General Meeting System
                        (eASY.KSEI) via the link: https://akses.ksei.co.id/ provided by
                        KSEI
The Meeting was chaired by Mr. Stefan Looho, as the President Commissioner, concurrently
serving as the Independent Commissioner of the Company, based on the resolution of the Board
of Commissioners Number: KEP-003/KOM-KF/V/2026 dated May 22, 2026, regarding the
Appointment of the Chairperson of the Extraordinary General Meeting of Shareholders of
PT Kimia Farma (Persero) Tbk.
A. Attendance of Board of Commissioners and Board of Directors
   The Meeting was physically attended by 5 (five) members of the Board of Commissioners and
   6 (six) members of the Board of Directors as follows:
            Board of Commissioners                             Board of Directors
    President            Mr. Stefan Looho          President Director     Mr. Djagad
    Commissioner,                                                         Prakasa Dwialam
    concurrently serving
    as      Independent
    Commissioner
    Commissioner         Mrs. Sumarjati            Director of Finance      Mr. Willy Meridian
                         Arjoso                    and Risk Management
    Independent          Mrs. Diah                 Director of Portfolio,   Mrs. Jasmine
    Commissioner         Kusumawardani             Product, and Service     Kamiasti Karsono
    Independent          Mr. Fachmi Idris          Director of Production   Mr. Hadi Kardoko
    Commissioner                                   and Supply Chain
    Commissioner         Mr. Suprianto             Director of Human        Mr. Disril Revolin
                                                   Resources                Putra
                                                   Director            of   Mr. Hanadi Setiarto
                                                   Commercial


                                               1
Page 2
B. Attendance Quorum of the Shareholders
   Pursuant to Article 26 paragraph (1) of the Company’s Articles of Association and Article 86
   paragraph (1) of Law Number 40 of 2007 concerning Limited Liability Companies, as amended
   by Law Number 6 of 2023 concerning the Stipulation of Government Regulation in Lieu of Law
   Number 2 of 2022 concerning Job Creation into Law (“Company Law”), for Agenda Items 1, 2,
   3, 4, and 5, the Meeting may be convened if attended by Shareholders representing more than
   ½ (one-half) of the total shares with valid voting rights.
   Pursuant to Article 26 paragraph (2) of the Company’s Articles of Association and Article 89
   paragraph (5) of the Company Law, for Agenda Item 6, the Meeting may be convened if
   attended by the Series A Dwiwarna Shareholder and the other Shareholders and/or their lawful
   proxies representing at least ¾ (three-fourths) of the total shares with valid voting rights.
   Pursuant to Article 26 paragraph (4) of the Company’s Articles of Association and Article 86
   paragraph (1) of the Company Law, for Agenda Item 7, the Meeting may be convened if
   attended by the Series A Dwiwarna Shareholder and the other Shareholders and/or their lawful
   proxies representing more than ½ (one-half) of the total shares with valid voting rights.
   Based on the Shareholders Register as of the Recording Date, namely Monday, 11 May 2026,
   and the Attendance List received from PT Datindo Entrycom as the Company’s Share Registrar,
   we hereby report that the Shareholders present and/or represented at this Meeting, whether
   physically present (offline), electronically present (online), or granting proxy through the e-Proxy
   eASY.KSEI facility, consist of 1 (one) Series A Dwiwarna share and 5.000.237.899 (Five billion
   two hundred thirty-seven thousand eight hundred ninety-nine) Series B shares, or in total
   5.000.237.900 (Five billion two hundred thirty-seven thousand nine hundred) shares,
   representing 89,8258753% of 5.566.589.677 (five billion five hundred sixty-six million five
   hundred eighty-nine thousand six hundred seventy-seven) shares, being the total number of
   shares with valid voting rights issued by the Company up to the date of the Meeting, consisting
   of:
     • 1 (one) Series A Dwiwarna share; and
     • 5.566.589.676 (five billion five hundred sixty-six million five hundred eighty-nine thousand
         six hundred seventy-six) Series B shares,
   with a nominal value of Rp100 (one hundred Rupiah) per share, constituting the total number of
   shares issued by the Company up to this date.


C. Meeting Agendas and Brief Explanation:
   1. Approval of the Company’s Annual Report for Fiscal Year 2025 and Ratification of
      the Company’s Consolidated Financial Statements for Fiscal Year 2025, the Board of
      Commissioners’ Supervisory Duties Report for Fiscal Year 2025, as well as
      Ratification of the Report on the Implementation of the Micro and Small Business
      Funding Program (Program Pendanaan Usaha Mikro dan Usaha Kecil/PUMK), and
      the granting of full release and discharge (volledig acquit et de charge) to the Board
      of Directors for the management actions of the Company and to the Board of
      Commissioners for the supervisory actions of the Company carried out during Fiscal
      Year 2025.


                                                  2
Page 3
   Brief Explanation:
   1. Pursuant to Article 12 paragraph (2) letter b in conjunction with Article 19 and Article 22
      paragraph (2) of the Company's Articles of Association, as well as Law Number 40 of
      2007 concerning Limited Liability Companies, as amended (the "Company Law"), it is
      stipulated that:
          a) the Board of Directors shall submit the Annual Report to the General Meeting of
             Shareholders (“GMS”) after it has been reviewed by the Board of Commissioners;
          b) the approval of the Annual Report, including the ratification of the financial
             statements and the report on the Supervisory Duties of the Board of
             Commissioners, shall be carried out by the GMS.

   2. Article 33 paragraph (1) of the Regulation of the Minister of State-Owned Enterprises
      Number PER-1/MBU/03/2023 of 2023 concerning Special Assignments and the Social
      and Environmental Responsibility Program of State-Owned Enterprises (“PerMen
      BUMN 01/2023”) stipulates that the financial statements and the report on the
      implementation of the SOE Social and Environmental Responsibility Program (TJSL
      BUMN) shall form an integral part of the quarterly reports and annual performance
      reports of SOEs, which shall be set out in a separate chapter.

2. Determination of the Salary/Honorarium, including Facilities and Allowances for
   Fiscal Year 2026, as well as Performance-Based Remuneration for Fiscal Year 2025
   for the Management of the Company.
   Brief Explanation:
   Pursuant to the Company’s Articles of Association, the Salary/Honorarium, Allowances and
   Facilities of the Board of Commissioners and the Board of Directors of the Company, as
   well as tantiem, must be resolved by the General Meeting of Shareholders (“GMS”).

3. Determination of the Public Accountant and/or Public Accounting Firm to Audit the
   Company’s Consolidated Financial Statements and the Financial Statements of the
   PUMK Program for Fiscal Year 2026.
   Brief Explanation:
   Pursuant to Article 22 of the Company’s Articles of Association and Article 59 paragraph
   (1) of Financial Services Authority Regulation Number 15/POJK.04/2020 concerning the
   Planning and Conduct of General Meetings of Shareholders of Public Companies, the
   appointment and dismissal of a Public Accountant and/or Public Accounting Firm that will
   provide audit services on annual historical financial information must be resolved at the
   General Meeting of Shareholders (“GMS”) of the Public Company by taking into
   consideration the proposal of the Board of Commissioners.

4. Delegation of Authority to Approve the Company's Long-Term Plan (Rencana Jangka
   Panjang Perusahaan or "RJPP") for the 2026–2030 Period and the Company's Work
   Plan and Budget (Rencana Kerja dan Anggaran Perusahaan or "RKAP") for Fiscal
   Year 2027, including any amendments thereto, from the General Meeting of
   Shareholders ("GMS") to a party designated by the GMS.

                                             3
Page 4
   Brief Explanation:
   Based on Article 17 paragraph (3) of the Company's Articles of Association concerning the
   Company's Long-Term Plan (RJPP) and Article 18 paragraph (2) concerning the
   Company's Work Plan and Budget (RKAP), it is stipulated that the RJPP and RKAP shall
   be approved by the GMS.

5. Report on the Implementation of the Conversion of Mandatory Convertible Bonds
   (OWK) into shares to increase the Company's capital, as well as approval of the
   granting of authority to the Company's Board of Commissioners to state the amount
   of the increase in issued and paid-up capital.
   Brief Explanation:
   Pursuant to Article 41 paragraphs (1) and (2) of Law Number 40 of 2007 concerning Limited
   Liability Companies, it is stipulated as follows:
    1) Any increase in the Company’s capital shall be carried out based on the approval of
        the GMS.
    2) The GMS may delegate authority to the Board of Commissioners to approve the
        implementation of the GMS resolution as referred to in paragraph (1) for a period of no
        longer than 1 (one) year.

6. Report on the Implementation of the Transfer/Disposal and Write-Off of the
   Company’s Assets representing more than 50% of the Company’s net assets, as
   approved in the Extraordinary General Meeting of Shareholders (“EGMS”) of the
   Company dated 3 November 2025.
   Brief Explanation:
   The Company has obtained approval from the Extraordinary General Meeting of
   Shareholders (“EGMS”) held on 3 November 2025 to carry out the Transfer/Disposition and
   Write-Off of the Company’s Assets representing more than 50% of the Company’s net
   assets for the Company’s purposes, which shall be conducted in the form of the sale of 38
   (thirty-eight) Company assets consisting of land and buildings, namely:
   a. 1 (one) land asset located in Cikarang with a value of Rp347 billion to PT Bio Farma
      (Persero), being the Company’s main shareholder with ownership of 89.82%, and
      therefore constituting an affiliated party.
   b. 37 (thirty-seven) other land and building assets to be disposed of through auction at the
      State Assets and Auction Service Office (Kantor Pelayanan Kekayaan Negara dan
      Lelang/KPKNL), which is planned to be conducted during the period from 2026 to 2029.
   The Company needs to report that, as of the date hereof, the transaction for the
   transfer/disposal and write-off of the Company's assets has not yet been implemented and
   will be carried out in compliance with the prevailing laws and regulations, including Financial
   Services Authority Regulation No. 42/POJK.04/2020 concerning Affiliated Transactions
   and Conflict of Interest Transactions and Financial Services Authority Regulation No.
   17/POJK.04/2020 concerning Material Transactions and Changes in Business Activities.




                                              4
Page 5
    7. Changes in the Composition of the Company’s Management
       Brief Explanation:
       Referring to the Company’s Articles of Association, the Board of Commissioners and the
       Board of Directors shall be appointed and dismissed by the GMS.

D. Opportunity for Questions and/or Opinions during the Meeting
   1. Each Meeting Agenda is given the opportunity to ask questions.
   2. Shareholders or their proxies have 3 (three) opportunities to submit questions and/or
       opinions at each discussion session on each Meeting Agenda.
   3. Submission of questions and/or opinions submitted orally cannot be responded to.
   4. The Chairperson of the Meeting may limit the time in the question-and-answer program for
       each Meeting Agenda.
   5. The process of submitting questions and/or opinions for Shareholders who are physically
       present at the Meeting (offline) is as follows:
        a. The Chairperson of the meeting will ask the shareholders if they have any questions or
            opinions to submit.
        b. Questions and/or opinions that have been written by the Shareholders are submitted
            to the officer to be submitted to the Notary and Chairperson of the Meeting or the party
            appointed to provide an explanation.
   6. The process of submitting questions and/or opinions for Shareholders electronically at the
       Meeting through eASY.KSEI, is as follows:
        a. Questions and/or opinions are submitted through the chat feature in the 'Electronic
            Option' column available on the E-Meeting Hall screen at eASY.KSEI;
        b. Questions and/or opinions can be submitted as long as the 'General Meeting Flow Text'
            column has the status of "discussion started for agenda item no. […]”.
   7. Questions and/or opinions that have been submitted by the Shareholders or their proxies
       are then submitted to the Notary to examine their validity/authority.
   8. Questions and/or opinions that have been examined by a Notary are submitted by officers
       to the Chairperson of the Meeting. The Chairperson of the Meeting will then read out the
       questions and/or opinions.
   9. The Chairperson of the Meeting has the right to refuse to answer questions and/or opinions
       that are not related to the Meeting Agenda being discussed or that have been previously
       asked.
   10. Members of the Board of Commissioners or members of the Board of Directors or parties
       appointed by the Chairperson of the Meeting will answer questions or respond to opinions
       that have been read out as referred to in point 9 above.
   11. The Chairperson of the Meeting has the authority to take the necessary actions to maintain
       the orderliness of the Meeting.




                                                 5
Page 6
E. Meeting Resolution Mechanism
    1. Meeting decisions are taken based on deliberation to reach a consensus. In the event that
       the Meeting decisions based on deliberation to reach a consensus is not reached, then the
       decision shall be taken by voting, with the following conditions:
        a. Pursuant to Article 26 paragraph (1) of the Company’s Articles of Association and
            Article 87 paragraph (2) of the Company Law, for Agenda Items 1, 2, 3, 4, and 5, a
            resolution shall be valid if approved by more than ½ (one-half) of the total shares with
            voting rights present at the Meeting.
        b. Pursuant to Article 26 paragraph (2) of the Company’s Articles of Association and
            Article 89 paragraph (5) of the Company Law, for Agenda Item 6, a resolution shall be
            valid if approved by the shareholders and/or their lawful proxies representing more than
            ¾ (three-fourths) of the total shares with voting rights present at the Meeting.
        c. Pursuant to Article 26 paragraph (4) of the Company’s Articles of Association and
            Article 87 paragraph (2) of the Company Law, for Agenda Item 7, a resolution shall be
            valid if approved by the Series A Dwiwarna Shareholde and the other shareholders
            and/or their lawful proxies representing more than ½ (one-half) of the total shares with
            voting rights present at the Meeting.
    2. Voting is conducted after all the questions have been answered and/or the question-and-
       answer time has expired.
    3. Each share gives the holder the right to cast 1 (one) vote. If a Shareholder owns more than
       1 (one) share, he/she is only required to give 1 (one) time and the vote represents all shares
       that he owns or represents.
    4. The electronic (online) voting process for Shareholders in the Meeting through eASY.KSEI
       (e-Voting) is carried out in the following manner:
         a. The voting process takes place on eASY.KSEI in the E-Meeting Hall menu, Live
              Broadcasting sub-menu;
         b. Shareholders who are present or grant electronic proxy in the Meeting through
              eASY.KSEI, but have not yet cast their vote, have the opportunity to cast their vote
              during the voting period through the E-Meeting Hall screen on eASY.KSEI;
         c. During the voting process, the ‘General Meeting Flow Text’ column will display the
              status “voting for agenda item no, [...] has started”;
         d. If a Shareholder does not cast a vote for an Agenda Item until the status of the
              Meeting displayed in the ‘General Meeting Flow Text” column changes to “voting for
              agenda item no [...] has ended”, then the Shareholder is considered to have
              abstained;
         e. Direct electronic voting per Agenda Item via eASY.KSEI is allocated a maximum of 5
              (five) minutes.
     5. Shareholders of shares with valid voting rights who are present at the Meeting but abstain,
        in accordance with the provisions of Article 47 of POJK No.15/POJK.04/2020 and Article
        25 paragraph (11) of the Articles of Association, shall be deemed to have cast votes in line
        with the majority of shareholders who cast votes.
     6. The Chair of the Meeting shall request the Notary to announce the results of the voting.
     7. The provisions referred to in this paragraph shall apply mutatis mutandis to Shareholders
        who grant proxy through e-Proxy.

                                                  6
Page 7
F. Independent Party for Vote Counting
   The Company has appointed independent parties, PT Datindo Entrycom to count and/or
   validate the votes.

G. Meeting Resolutions
   Whereas the Meeting has resolved the following resolutions as set forth in “Minutes of the
   General Meeting of Shareholders of PT PERUSAHAAN PERSEROAN (PERSERO) PT KIMIA
   FARMA Tbk, abbreviated as PT KIMIA FARMA (PERSERO) Tbk”, Deed No. 02 dated 3 June
   2026, made before Dewantari Handayani, S.H., MPA, Notary, the substance of which is as
   follows:

First Meeting Agenda:
Approval of the Company’s Annual Report for Fiscal Year 2025 and Ratification of the Company’s
Consolidated Financial Statements for Fiscal Year 2025, the Board of Commissioners’ Supervisory
Duties Report for Fiscal Year 2025, as well as Ratification of the Report on the Implementation of
the Micro and Small Business Funding Program (Program Pendanaan Usaha Mikro dan Usaha
Kecil/PUMK), and the granting of full release and discharge (volledig acquit et de charge) to the
Board of Directors for the management actions of the Company and to the Board of Commissioners
for the supervisory actions of the Company carried out during Fiscal Year 2025.

Number of Questioners
None of the Shareholders asked questions in the First Meeting Agenda.

Voting Calculations
                                                          AGREE (Including the Series A
         DISAGREE                     ABSTAIN
                                                            Dwiwarna Shareholder)
      200.100 shares or        0 share or 0,0000000%         5.000.037.800 shares or
        0,0040018%                                                99,9959982%

Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.037.800 (five billion thirty-seven thousand eight
hundred) shares, representing 99,9959982% (ninety-nine point nine nine five nine nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:

 1. To approve the Company’s Annual Report, including the Supervisory Duties Report of the
    Company’s Board of Commissioners for the Financial Year 2025 ended on 31 December 2025.
 2. To Ratify:
     a. The Company’s Consolidated Financial Statements for the Financial Year 2025 ended on
        31 December 2025, which were audited by the Public Accounting Firm Heliantono &
        Rekan pursuant to Report Number 00425/2.0459/AU.1/04/0916-2/1/III/2026 dated 31
        March 2026, expressing an unqualified opinion in all material respects; and



                                                7
Page 8
       b. The Financial Statements of the Micro and Small Business Financing Program (PUMK)
          for the 2025 Fiscal Year ending on December 31, 2025, which have been audited by the
          Public Accounting Firm Heliantono & Partners in accordance with Report No.
          00760/2.0459/AU.8/04/0916-2/1/IV/2026 dated April 30, 2026, with an unqualified opinion
          in all material respects.
3.   With the approval of the Company’s Annual Report, including the Supervisory Duties Report
     of the Board of Commissioners, and the ratification of the Company’s Consolidated Financial
     Statements as well as the Financial Statements of the PUMK Program, all for the Financial
     Year 2025 ended on 31 December 2025, the GMS hereby grants full release and discharge
     (volledig acquit et de charge) to all members of the Board of Directors for the management
     actions of the Company and to all members of the Board of Commissioners for the supervisory
     actions of the Company carried out during the Financial Year 2025 ended on 31 December
     2025, insofar as such actions do not constitute criminal acts and/or violations of the prevailing
     laws and regulations and are reflected in the aforesaid reports.

Second Meeting Agenda:
Determination of the Salary/Honorarium, including Facilities and Allowances for Fiscal Year 2026,
as well as Performance-Based Remuneration for Fiscal Year 2025 for the Management of the
Company.

Number of Questioners
None of the Shareholders asked questions in the Second Meeting Agenda.

Voting Calculations
                                                             AGREE (Including the Series A
          DISAGREE                     ABSTAIN
                                                               Dwiwarna Shareholder)
      200.100 shares or         0 share or 0,0000000%           5.000.037.800 shares or
        0,0040018%                                                   99,9959982%
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.037.800 (five billion thirty-seven thousand eight
hundred) shares, representing 99,9959982% (ninety-nine point nine nine five nine nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
Approving the delegation of authority to:
1. The majority of Series B Shareholders to appoint members of the Board of Commissioners; and
2. The Board of Commissioners, after first obtaining written approval from the majority of Series B
   Shareholders, shall determine for members of the Board of Directors
the following salaries/honoraria, benefits, and allowances for Fiscal Year 2026 and performance-
based compensation for Fiscal Year 2025 in accordance with applicable regulations.




                                                  8
Page 9
Third Meeting Agenda:
Determination of the Public Accountant and/or Public Accounting Firm to Audit the Company’s
Consolidated Financial Statements and the Financial Statements of the PUMK Program for Fiscal
Year 2026.

Number of Questioners
None of the Shareholders asked questions in the Third Meeting Agenda.

Voting Calculations
                                                          AGREE (Including the Series A
         DISAGREE                    ABSTAIN
                                                            Dwiwarna Shareholder)
      200.100 shares or           20.000 shares of           5.000.017.800 shares or
        0,0040018%                  0,0004000%                    99,9955982%
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.037.800 (five billion thirty-seven thousand eight
hundred) shares, representing 99,9959982% (ninety-nine point nine nine five nine nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
1. To grant authority and power to the Board of Commissioners of the Company, subject to
   obtaining prior approval from the majority Series B Shareholder, to determine the appointment
   of a Public Accountant and/or Public Accounting Firm to audit the Company’s Consolidated
   Financial Statements for Fiscal Year 2026 and other periods within Fiscal Year 2026, and/or
   to audit certain specific financial statements in 2026, as well as the Financial Statements and
   the Implementation of the Micro and Small Enterprise (MSE) Funding Program for Fiscal Year
   2026.
2. To grant authority and power to the Board of Commissioners, subject to obtaining prior
   approval from the majority Series B Shareholder, to determine the appointment of a Public
   Accountant and/or Public Accounting Firm to audit the Company’s Consolidated Financial
   Statements for other periods within Fiscal Year 2026 for the purposes and interests of the
   Company.
3. To grant authority and power to the Board of Commissioners of the Company, subject to
   obtaining prior written approval from the majority Series B Shareholder, to determine the audit
   fees and other terms and conditions for such Public Accountant and/or Public Accounting
   Firm, and to appoint a replacement Public Accountant and/or Public Accounting Firm should
   the appointed Public Accountant and/or Public Accounting Firm, for any reason whatsoever,
   be unable to complete the audit of the Company’s Consolidated Financial Statements and the
   Financial Statements and the Implementation of the Micro and Small Enterprise (MSE)
   Funding Program for Fiscal Year 2026, including determining the audit fees and other terms
   and conditions for such replacement Public Accountant and/or Public Accounting Firm.




                                                9
Page 10
Fourth Meeting Agenda:
Delegation of Authority to Approve the Company's Long-Term Plan (Rencana Jangka Panjang
Perusahaan or "RJPP") for the 2026–2030 Period and the Company's Work Plan and Budget
(Rencana Kerja dan Anggaran Perusahaan or "RKAP") for Fiscal Year 2027, including any
amendments thereto, from the General Meeting of Shareholders ("GMS") to a party designated by
the GMS.

Number of Questioners
None of the Shareholders asked questions in the Fourth Meeting Agenda.

Voting Calculations
                                                           AGREE (Including the Series A
         DISAGREE                     ABSTAIN
                                                             Dwiwarna Shareholder)
      220.100 shares or        0 share or 0,0000000%          5.000.017.800 shares or
        0,0044018%                                                 99,9955982%
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.017.800 (five billion seventeen thousand eight
hundred) shares, representing 99,9955982% (ninety-nine point nine nine five five nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
To approve the granting of authority and power to the Company’s Board of Commissioners, upon
obtaining prior written approval from the holder of the majority Series B Shares, to approve the
Company’s Long-Term Corporate Plan (RJPP) for 2026–2030 and the Company’s Annual Work
Plan and Budget (RKAP) for 2027, including any amendments thereto. The approval of the
Company’s RJPP for 2026–2030 and RKAP for 2027, including any amendments thereto, shall be
carried out in accordance with good corporate governance principles and the prevailing
regulations, with due regard to the principles of fairness and disclosure of information, and shall
have been coordinated with the holder of the Series A Dwiwarna Share or its proxy for
synchronization with Government policies.
Fifth Meeting Agenda:
Report on the Implementation of the Conversion of Mandatory Convertible Bonds (OWK) into
shares to increase the Company's capital, as well as approval of the granting of authority to the
Company's Board of Commissioners to state the amount of the increase in issued and paid-up
capital.

Number of Questioners
None of the Shareholders asked questions in the Fifth Meeting Agenda.




                                                10
Page 11
Voting Calculations
                                                          AGREE (Including the Series A
         DISAGREE                    ABSTAIN
                                                            Dwiwarna Shareholder)
      200.100 shares or           20.000 shares of           5.000.017.800 shares or
        0,0040018%                  0,0004000%                    99,9955982%
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.037.800 (five billion thirty-seven thousand eight
hundred) shares, representing 99,9959982% (ninety-nine point nine nine five nine nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
1. Accept the Report on the Implementation of the Conversion of Mandatory Convertible Bonds
   (Obligasi Wajib Konversi/OWK) into the Company's shares in connection with the increase of
   the Company's capital.
2. Approve the granting of authority and power to the Board of Commissioners of the Company
   to declare the amount of the increase in the Company's issued and paid-up capital resulting
   from the conversion of the Company's Mandatory Convertible Bonds (OWK), as reflected in
   Article 4 paragraph (2) and Article 4 paragraph (3) of the Company's Articles of Association,
   and to take all necessary actions in connection therewith in compliance with the prevailing
   laws and regulations.
3. Grant an extension of authority and power to the Board of Commissioners of the Company,
   with the right of substitution, to set forth and declare all matters resolved under this agenda
   item in a notarial deed and to submit the same to the competent authorities in order to obtain
   approval and/or acknowledgment of receipt of notification of the amendment to the Articles of
   Association, and to take all actions deemed necessary and useful for such purposes without
   any exception whatsoever, including making any additions and/or amendments to such
   amendment to the Articles of Association if required.

Sixth Meeting Agenda:
Report on the Implementation of the Transfer/Disposal and Write-Off of the Company’s Assets
representing more than 50% of the Company’s net assets, as approved in the Extraordinary
General Meeting of Shareholders (“EGMS”) of the Company dated 3 November 2025.

Number of Questioners
None of the Shareholders asked questions in the Sixth Meeting Agenda.

Voting Calculations
                                                          AGREE (Including the Series A
         DISAGREE                    ABSTAIN
                                                            Dwiwarna Shareholder)
      220.100 shares or       0 share or 0,0000000%          5.000.017.800 shares or
        0,0044018%                                                99,9955982%



                                               11
Page 12
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.017.800 (five billion seventeen thousand eight
hundred) shares, representing 99,9955982% (ninety-nine point nine nine five five nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
Accept the Report on the Implementation of the Transfer/Disposal and Write-off of the Company's
Assets representing more than 50% (fifty percent) of the Company's net assets, as approved by
the Company's Extraordinary General Meeting of Shareholders (EGMS) held on 3 November
2025.

Seventh Meeting Agenda:
Changes in the Composition of the Company’s Management.

Number of Questioners
None of the Shareholders asked questions in the Seventh Meeting Agenda.

Voting Calculations
                                                           AGREE (Including the Series A
         DISAGREE                     ABSTAIN
                                                             Dwiwarna Shareholder)
      220.100 shares or        0 share or 0,0000000%          5.000.017.800 shares or
        0,0044018%                                                 99,9955982%
Pursuant to Article 47 of OJK Regulation Number 15/POJK.04/2020 and Article 26 paragraph (10)
of the Company’s Articles of Association, Shareholders casting abstention votes shall be deemed
to have cast the same vote as the majority vote of the Shareholders casting votes. Accordingly,
the Meeting, by majority vote totaling 5.000.017.800 (five billion seventeen thousand eight
hundred) shares, representing 99,9955982% (ninety-nine point nine nine five five nine eight two
percent) of the total votes cast at the Meeting, resolved as follows:
Considering the provisions of Article 65 paragraph (1) of the Regulation of the Minister of State-
Owned Enterprises (SOE) Number PER-3/MBU/03/2023 concerning the Organs and Human
Resources of State-Owned Enterprises, the Articles of Association of PT Kimia Farma Tbk, the
Special Power of Attorney Number SKK-42/MBU/10/2023 dated 13 October 2023, the Letter of
the Head of the State-Owned Enterprises Governance Agency (BP BUMN) Number SR-
277/BP/06/2026 dated 3 June 2026 regarding the Proposed Changes to the Management of PT
Kimia Farma (Persero) Tbk (a subsidiary of PT Bio Farma (Persero)), and the Letter of
Appointment from the President Director of PT Bio Farma (Persero) to the Director of Human
Capital of PT Bio Farma (Persero) Number SD-012.02/DIR/VI/2026 dated 2 June 2026, as follows:
  1. To approve the honorable dismissal of Mrs. Jasmine Kamiasti Karsono from her position as
     Director of Portfolio, Products & Services of PT Kimia Farma (Persero) Tbk.




                                               12
Page 13
2. To approve the change in the nomenclature of the position of a member of the Board of
   Directors of PT Kimia Farma (Persero) Tbk as follows:
                  Current Position                                New Position

      Director of Portfolio, Products & Services                        -

3. To approve the appointment of Mr. Bonanza Perwira Taihitu as Commissioner of PT Kimia
   Farma (Persero) Tbk.
4. The dismissal, change in position nomenclature, and appointment of members of the Board
   of Directors and Board of Commissioners of PT Kimia Farma (Persero) Tbk as referred to in
   points 1, 2, and 3 above shall be resolved at the General Meeting of Shareholders (GMS) of
   PT Kimia Farma (Persero) Tbk, with due regard to the provisions of the Company's Articles
   of Association and the prevailing laws and regulations.
5. To grant authority to the Board of Directors of PT Kimia Farma (Persero) Tbk, with the right
   of substitution, to formalize the resolutions in an authentic deed before a notary or other
   authorized official, and to report the same to PT Bio Farma (Persero) as the Attorney-in-Fact
   of the Holder of Series A Dwiwarna Shares of PT Kimia Farma (Persero) Tbk.


                                  Jakarta, June 5, 2026
                              PT Kimia Farma (Persero) Tbk
                                   Board of Directors




                                             13

File

File Open PDF
Source IDX
Size0.3 MB
Published5 Jun 2026
Pages13
Characters37,684
Text sourceEmbedded text layer
OCR confidence—

Names mentioned 25 people and organisations named in the text · linked when the evidence is strong

linked org KIMIA FARMA (PERSERO) Tbk p.1 ×44
linked person Hadi Kardoko p.1
linked person Disril Revolin p.1
possible person Stefan Looho p.1 ×3
possible person Fachmi Idris p.1
possible person Suprianto · Commissioner p.1
possible org PT Bio Farma (Persero) p.4 ×9
unresolved person Djagad · President Director p.1 ×2
unresolved person Sumarjati · Commissioner p.1
unresolved person Willy Meridian Arjoso p.1 ×2
unresolved person Diah p.1
unresolved person Jasmine p.1
unresolved person Kusumawardani · Commissioner p.1
unresolved org Disril Revolin Resources p.1
unresolved person Hanadi Setiarto Commercial p.1 ×2
unresolved org PT Datindo Entrycom p.2 ×2
unresolved org Minister of State-Owned Enterprises Number PER- p.3
unresolved org Financial Services Authority p.3 ×3
unresolved org PT PERUSAHAAN PERSEROAN (PERSERO) p.7
unresolved person Dewantari Handayani · Notaris p.7
unresolved org Public Accounting Firm Heliantono & Rekan p.7
unresolved org Public Accounting Firm Heliantono & Partners p.8
unresolved org Minister of State-Owned Enterprises p.12
unresolved person Jasmine Kamiasti Karsono p.12
unresolved person Bonanza Perwira Taihitu · Commissioner p.13 ×2

Extraction attempts how the parser did, and what it refused

Nothing structured was extracted from this document — the attempts below say why.

Rule parser Needs review confidence 0.000 982 ms 12 Sep 2026 22:15

no RUPS minutes content - likely misclassified

↑↓ select ↵ open ⇧↵ see every result